Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision label v3.4.2 was added to the study documents, replacing the previous v3.4.1.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded the CheckMate 577 NEJM publication entry with full author list and erratum citation; removed the previous NEJM entry and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded new metadata/UI elements including a glossary toggle, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and revision v3.4.0. Removed older metadata fields: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and revision v3.3.4.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now lists a broader set of study locations across multiple countries and regions, expanding the geographic coverage of sites. Some locations have been reorganized or removed.SummaryDifference3%

- Check89 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.